These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27058447)

  • 1. De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.
    Mencacci NE; Kamsteeg EJ; Nakashima K; R'Bibo L; Lynch DS; Balint B; Willemsen MA; Adams ME; Wiethoff S; Suzuki K; Davies CH; Ng J; Meyer E; Veneziano L; Giunti P; Hughes D; Raymond FL; Carecchio M; Zorzi G; Nardocci N; Barzaghi C; Garavaglia B; Salpietro V; Hardy J; Pittman AM; Houlden H; Kurian MA; Kimura H; Vissers LE; Wood NW; Bhatia KP
    Am J Hum Genet; 2016 Apr; 98(4):763-71. PubMed ID: 27058447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial choreoathetosis due to novel heterozygous mutation in PDE10A.
    Narayanan DL; Deshpande D; Das Bhowmik A; Varma DR; Dalal A
    Am J Med Genet A; 2018 Jan; 176(1):146-150. PubMed ID: 29130591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the genotype-phenotype landscape of PDE10A-associated movement disorders.
    Bohlega S; Abusrair AH; Al-Qahtani Z; Guzmán-Vega FJ; Ramakrishnan R; Aldosari H; Aldakheel A; Al-Qahtani S; Monies D; Arold ST
    Parkinsonism Relat Disord; 2023 Mar; 108():105323. PubMed ID: 36805523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea.
    Salpietro V; Perez-Dueñas B; Nakashima K; San Antonio-Arce V; Manole A; Efthymiou S; Vandrovcova J; Bettencourt C; Mencacci NE; Klein C; Kelly MP; Davies CH; Kimura H; Macaya A; Houlden H
    Mov Disord; 2018 Mar; 33(3):482-488. PubMed ID: 29392776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
    D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
    J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy.
    Diggle CP; Sukoff Rizzo SJ; Popiolek M; Hinttala R; Schülke JP; Kurian MA; Carr IM; Markham AF; Bonthron DT; Watson C; Sharif SM; Reinhart V; James LC; Vanase-Frawley MA; Charych E; Allen M; Harms J; Schmidt CJ; Ng J; Pysden K; Strick C; Vieira P; Mankinen K; Kokkonen H; Kallioinen M; Sormunen R; Rinne JO; Johansson J; Alakurtti K; Huilaja L; Hurskainen T; Tasanen K; Anttila E; Marques TR; Howes O; Politis M; Fahiminiya S; Nguyen KQ; Majewski J; Uusimaa J; Sheridan E; Brandon NJ
    Am J Hum Genet; 2016 Apr; 98(4):735-43. PubMed ID: 27058446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDE10A Mutation as an Emerging Cause of Childhood-Onset Hyperkinetic Movement Disorders: A Review of All Published Cases.
    Kalampokini S; Xiromerisiou G; Bargiotas P; Anastasiadou VC; Costeas P; Hadjigeorgiou GM
    Neuropediatrics; 2024 Aug; 55(4):217-223. PubMed ID: 38442915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chorea-related mutations in PDE10A result in aberrant compartmentalization and functionality of the enzyme.
    Tejeda GS; Whiteley EL; Deeb TZ; Bürli RW; Moss SJ; Sheridan E; Brandon NJ; Baillie GS
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):677-688. PubMed ID: 31871190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A.
    Strick CA; James LC; Fox CB; Seeger TF; Menniti FS; Schmidt CJ
    Neuropharmacology; 2010 Feb; 58(2):444-51. PubMed ID: 19765598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A familial case of PDE10A-associated childhood-onset chorea with bilateral striatal lesions.
    Miyatake S; Koshimizu E; Shirai I; Kumada S; Nakata Y; Kamemaru A; Nakashima M; Mizuguchi T; Miyake N; Saitsu H; Matsumoto N
    Mov Disord; 2018 Jan; 33(1):177-179. PubMed ID: 29165877
    [No Abstract]   [Full Text] [Related]  

  • 11. Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP.
    Handa N; Mizohata E; Kishishita S; Toyama M; Morita S; Uchikubo-Kamo T; Akasaka R; Omori K; Kotera J; Terada T; Shirouzu M; Yokoyama S
    J Biol Chem; 2008 Jul; 283(28):19657-64. PubMed ID: 18477562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
    Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
    Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology.
    Giorgi M; Melchiorri G; Nuccetelli V; D'Angelo V; Martorana A; Sorge R; Castelli V; Bernardi G; Sancesario G
    Neurobiol Dis; 2011 Jul; 43(1):293-303. PubMed ID: 21515371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.
    Padovan-Neto FE; Sammut S; Chakroborty S; Dec AM; Threlfell S; Campbell PW; Mudrakola V; Harms JF; Schmidt CJ; West AR
    J Neurosci; 2015 Apr; 35(14):5781-91. PubMed ID: 25855188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.
    Soderling SH; Bayuga SJ; Beavo JA
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):7071-6. PubMed ID: 10359840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.
    Russwurm C; Koesling D; Russwurm M
    J Biol Chem; 2015 May; 290(19):11936-47. PubMed ID: 25762721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET imaging shows loss of striatal PDE10A in patients with Huntington disease.
    Ahmad R; Bourgeois S; Postnov A; Schmidt ME; Bormans G; Van Laere K; Vandenberghe W
    Neurology; 2014 Jan; 82(3):279-81. PubMed ID: 24353339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A).
    Fujishige K; Kotera J; Michibata H; Yuasa K; Takebayashi S; Okumura K; Omori K
    J Biol Chem; 1999 Jun; 274(26):18438-45. PubMed ID: 10373451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
    Hebb AL; Robertson HA; Denovan-Wright EM
    Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased social interaction in mice deficient of the striatal medium spiny neuron-specific phosphodiesterase 10A2.
    Sano H; Nagai Y; Miyakawa T; Shigemoto R; Yokoi M
    J Neurochem; 2008 Apr; 105(2):546-56. PubMed ID: 18088367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.